Australia ASX Index: Health Care data was reported at 41,403.700 Point in Apr 2025. This records an increase from the previous number of 40,528.700 Point for Mar 2025. Australia ASX Index: Health Care data is updated monthly, averaging 14,192.400 Point from Apr 2002 (Median) to Apr 2025, with 277 observations. The data reached an all-time high of 47,852.600 Point in Aug 2021 and a record low of 2,961.600 Point in May 2003. Australia ASX Index: Health Care data remains active status in CEIC and is reported by Australian Securities Exchange. The data is categorized under Global Database’s Australia – Table AU.Z001: Australian Stock Exchange: Indices. The Health Care Index (XHJ) encompasses two main industry groups. The first includes companies who manufacture health care equipment and supplies or provide health care related services, and owners and operators of health care products, providers of basic health-care services, and owners and operators of health care facilities and organisations. The second group includes companies primarily involved in the research, development, production and marketing of pharmaceuticals and biotechnology products.

Australia Hospital Market was valued at USD 57.23 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.98% through 2029.

Pages	80
Market Size	2023: USD 57.23 Billion
Forecast Market Size	2029: USD 81.44 Billion
CAGR	2024-2029: 5.98%
Fastest Growing Segment	Specialty
Largest Market	New South Wales
Key Players	1. Ramsay Health Care 2. Healthscope Ltd. 3. St John of God Health Care 4. Healthe Care Australia Pty Ltd. 5. Cura Day Hospitals Group 6. Western Private Hospital 7. SA Health 8. Alfred Health 9. St Vincent's Health Australia 10. The Royal Children's Hospital

Snapshot img

Hospital Furniture Market Size 2024-2028

The hospital furniture market size is forecast to increase by USD 8 billion, at a CAGR of 8.06% between 2023 and 2028.

The market is experiencing significant growth due to the increasing international accreditation of hospitals. This trend is driven by the increasing emphasis on providing high-quality patient care and facilities that meet international standards. However, this market also faces challenges, primarily from the growing geriatric population and the limited sustainability of smaller companies. The geriatric population's increasing need for specialized furniture and medical equipment is putting pressure on hospitals to invest in more comfortable and accessible solutions. Meanwhile, The market's competitive landscape is fragmented, with numerous small companies struggling to remain profitable. These companies face challenges in meeting the demand for high-quality, cost-effective solutions while also competing with larger, more established players.
Companies seeking to capitalize on market opportunities must focus on innovation, sustainability, and cost-effectiveness to differentiate themselves and meet the evolving needs of hospitals and their patients. Additionally, collaborations and partnerships with healthcare providers and industry associations can help smaller companies gain market share and build a strong brand presence. Overall, the market presents both opportunities and challenges, requiring strategic planning and a focus on meeting the unique needs of healthcare providers and their patients.

What will be the Size of the Hospital Furniture Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The market continues to evolve, with dynamic market activities shaping its landscape. HVAC systems are integrated into hospital designs to ensure optimal indoor air quality, enhancing patient and staff comfort. Work flow optimization and supply chain management are crucial for efficient operations, while infection prevention remains a top priority. Medical cabinets and medical carts facilitate easy access to essential medical equipment, and hospital beds and operating tables are designed for patient comfort and safety. Space planning is essential for maximizing efficiency in healthcare facilities, with sterilization equipment and infection control measures integrated into the design.

Steel furniture offers durability and strength, while anesthesia machines and biomedical engineering solutions enable advanced medical procedures. Patient handling equipment, including patient lifts and overbed tables, ensures safe patient transfer and positioning. Customizable furniture caters to the unique needs of various sectors, such as nursing homes and rehabilitation centers. Antimicrobial coatings and material science advancements contribute to hygiene standards, while fire safety and weight capacity are critical considerations. Staff training and regulatory compliance are ongoing priorities, ensuring the effective use of all furniture and equipment. Modular furniture offers flexibility in design and layout, while iv poles and storage cabinets cater to the diverse needs of healthcare facilities.

Electrical systems and medical imaging systems are integrated into the furniture design for seamless functionality. Patient comfort and patient monitors are essential for positive patient experiences, with patient lifts and nursing home furniture designed to cater to the specific needs of elderly patients. The market is characterized by continuous innovation and adaptation to meet the evolving needs of healthcare facilities and patients. From HVAC systems to medical imaging systems, every aspect of hospital furniture is designed with patient safety, staff efficiency, and infection prevention in mind. The ongoing integration of technology and material science advancements ensures that hospital furniture remains a vital component of modern healthcare facilities.

How is this Hospital Furniture Industry segmented?

The hospital furniture industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Application

  Physician furniture
  Patient furniture
  Staff furniture


Product

  Hospital beds
  Specialty medical chairs and tables
  Others


Geography

  North America

    US
    Canada


  Europe

    Germany
    UK


  APAC

    China


  Rest of World (ROW)

By Application Insights

The physician furniture segment is estimated to witness significant growth during the forecast period.

The healthcare sector's evolution has led to an increased focus on creating advanced and comforta

Australia ASX Index: Health Care data was reported at 40,528.700 Point in Mar 2025. This records a decrease from the previous number of 42,753.100 Point for Feb 2025. Australia ASX Index: Health Care data is updated monthly, averaging 14,089.400 Point from Apr 2002 (Median) to Mar 2025, with 276 observations. The data reached an all-time high of 47,852.600 Point in Aug 2021 and a record low of 2,961.600 Point in May 2003. Australia ASX Index: Health Care data remains active status in CEIC and is reported by Australian Securities Exchange. The data is categorized under Global Database’s Australia – Table AU.Z001: Australian Stock Exchange: Indices. The Health Care Index (XHJ) encompasses two main industry groups. The first includes companies who manufacture health care equipment and supplies or provide health care related services, and owners and operators of health care products, providers of basic health-care services, and owners and operators of health care facilities and organisations. The second group includes companies primarily involved in the research, development, production and marketing of pharmaceuticals and biotechnology products.

IntroductionUnderstanding Indigenous women’s dissatisfaction with birthing experiences is vital for improving maternal healthcare. It highlights the need for compassionate, respectful care that meets women’s physical and emotional needs. Addressing these concerns can enhance patient satisfaction, reduce postpartum mental health issues and wellness, and ensure safer, more positive outcomes for mothers and babies.ObjectivesThis scoping review aimed to identify what is known about Indigenous women’s dissatisfaction of birthing experiences in mainstream maternity hospitals.Inclusion criteriaThis review considered primary research studies that reported on reasons for dissatisfaction of birthing experiences, and strategies implemented to improve quality of clinical practice around women’s dissatisfaction of birthing experiences in mainstream maternity hospitals in Australia, Aotearoa, Canada, US, Kalaallit Nunaat and Sápmi.FindingsA total of 22 manuscripts reporting 22 studies met the inclusion criteria and were included in the synthesis.DiscussionThere is a need for culturally safe trauma informed care, inclusive communication, active decision-making involvement and greater inclusion of Indigenous perspectives in maternity care, including the involvement of Indigenous birth support workers where appropriate and inclusion of Birthing on Country models of care.ConclusionThis review reveals that the medicalisation and evacuation of Indigenous women for childbirth cause cultural, geographic, and social disconnection, despite infant safety benefits. It underscores the need for better cultural safety education, communication, and the inclusion of cultural practices in care, with support from Indigenous birth support workers being essential.

Employment: Australian Capital Territory: Health Care and Social Assistance data was reported at 35.782 Person th in Feb 2025. This records a decrease from the previous number of 37.746 Person th for Nov 2024. Employment: Australian Capital Territory: Health Care and Social Assistance data is updated quarterly, averaging 16.557 Person th from Nov 1984 (Median) to Feb 2025, with 162 observations. The data reached an all-time high of 37.746 Person th in Nov 2024 and a record low of 6.104 Person th in Nov 1984. Employment: Australian Capital Territory: Health Care and Social Assistance data remains active status in CEIC and is reported by Australian Bureau of Statistics. The data is categorized under Global Database’s Australia – Table AU.G022: Employment: by State and by Industry.

Australia Respiratory Care Devices Market is anticipated to reach an exponential growth in the upcoming five years. Australia Respiratory Care Devices Market - Industry Size, Share, Trends, Competition, Opportunity and Forecast 2027 By Product Type, By Indication, By End User, By Region, Competition Forecast & Opportunities, 2027

Pages	70
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

The market is expected to reach USD 16.0 million by 2025 and is likely to grow at an estimated 4.6% CAGR from 2025 to 2035.

Attributes	Details
Estimated Value (2035)	USD 16.0 million
Value-based CAGR (2025 to 2035)	4.6%

Market Concentration

Vendor Tier	Tier 1
Key Vendors	Indivior, Alkermes, Camurus
Market Share (%)	60%
Description	Global leaders offering MAT solutions, including long-acting buprenorphine and extended-release naltrexone.

Vendor Tier	Tier 2
Key Vendors	Teva Pharmaceuticals, Aspen Pharma
Market Share (%)	25%
Description	Regional manufacturers providing affordable MAT options and generic formulations.

Vendor Tier	Tier 3
Key Vendors	Harm Reduction Australia, Telehealth NZ
Market Share (%)	15%
Description	Non-profits and digital health platforms delivering accessible and innovative care solutions.

This dataset presents the footprint of the percentage of adults who saw a GP for urgent medical care in the preceding 12 months. The data spans the years of 2013-2017 and is aggregated to 2015 Department of Health Primary Health Network (PHN) areas, based on the 2011 Australian Statistical Geography Standard (ASGS).

The data is sourced from the Australian Bureau of Statistics (ABS) 2016-17 Patient Experience Survey, collected between 1 July 2016 and 30 June 2017. It also includes data from previous Patient Experience Surveys conducted in 2013-14, 2014- 15 and 2015-16. The Patient Experience Survey is conducted annually by the ABS and collects information from a representative sample of the Australian population. The Patient Experience Survey is one of several components of the Multipurpose Household Survey, as a supplement to the monthly Labour Force Survey. The Patient Experience Survey collects data on persons aged 15 years and over, who are referred to as adults for this data collection.

For further information about this dataset, visit the data source: Australian Institute of Health and Welfare - Patient experiences in Australia Data Tables.: https://www.aihw.gov.au/reports/primary-health-care/patient-experiences-in-australia-in-2016-17/data

Please note:

• AURIN has spatially enabled the original data using the Department of Health - PHN Areas.: https://www1.health.gov.au/internet/main/publishing.nsf/Content/PHN-Home
• Percentages are calculated based on counts that have been randomly adjusted by the ABS to avoid the release of confidential data.
• As an indication of the accuracy of estimates, 95% confidence intervals were produced. These were calculated by the ABS using standard error estimates of the proportion.
• Some of the patient experience measures for 2016-17 have age-standardised rates presented. Age-standardised rates are hypothetical rates that would have been observed if the populations studied had the same age distribution as the standard population.
• Crude rates are provided for all years. They should be used for understanding the patterns of actual service use or level of experience in a particular PHN.
• The Patient Experience Survey excludes persons aged less than 15 years, persons living in non-private dwellings and the Indigenous Community Strata (encompassing discrete Aboriginal and Torres Strait Islander communities).
• Data for Northern Territory should be interpreted with caution as the Patient Experience Survey excluded the Indigenous Community Strata, which comprises around 25% of the estimated resident population of the Northern Territory living in private dwellings.
• Rows that contain a "#" in "Interpret with Caution" indicates that the estimate has a relative standard error of 25% to 50%, which indicates a high level of sampling error relative to its value and must be taken into account when comparing this estimate with other values.
• NP - Not available for publication. The estimate is considered to be unreliable. Values assigned to NP in the original data have been set to null.

Australia Health Insurance: Number of Policies: Hospital Treatment: by Category: Single data was reported at 2,964,265.000 Unit in Dec 2024. This records an increase from the previous number of 2,951,147.000 Unit for Sep 2024. Australia Health Insurance: Number of Policies: Hospital Treatment: by Category: Single data is updated quarterly, averaging 2,311,044.500 Unit from Sep 1995 (Median) to Dec 2024, with 118 observations. The data reached an all-time high of 2,964,265.000 Unit in Dec 2024 and a record low of 1,237,674.000 Unit in Dec 1998. Australia Health Insurance: Number of Policies: Hospital Treatment: by Category: Single data remains active status in CEIC and is reported by Australian Prudential Regulation Authority. The data is categorized under Global Database’s Australia – Table AU.RG006: Health Insurance: Number of Policies.

This dataset presents the footprint of the percentage of adults who reported they were covered by private health insurance in the preceding 12 months, by Primary Health Network (PHN) area. The data spans the years of 2015-2016 and is aggregated to 2015 Department of Health Primary Health Network (PHN) areas, based on the 2011 Australian Statistical Geography Standard (ASGS).

The data is sourced from the Australian Bureau of Statistics (ABS) 2016-17 Patient Experience Survey, collected between 1 July 2016 and 30 June 2017. It also includes data from previous Patient Experience Surveys conducted in 2013-14, 2014-15 and 2015-16. The Patient Experience Survey is conducted annually by the ABS and collects information from a representative sample of the Australian population. The Patient Experience Survey is one of several components of the Multipurpose Household Survey, as a supplement to the monthly Labour Force Survey. The Patient Experience Survey collects data on persons aged 15 years and over, who are referred to as adults for this data collection.

For further information about this dataset, visit the data source:Australian Institute of Health and Welfare - Patient experiences in Australia Data Tables.

Please note:

• AURIN has spatially enabled the original data using the Department of Health - PHN Areas.

• Percentages are calculated based on counts that have been randomly adjusted by the ABS to avoid the release of confidential data.

• As an indication of the accuracy of estimates, 95% confidence intervals were produced. These were calculated by the ABS using standard error estimates of the proportion.

• Some of the patient experience measures for 2016-17 have age-standardised rates presented. Age-standardised rates are hypothetical rates that would have been observed if the populations studied had the same age distribution as the standard population.

• Crude rates are provided for all years. They should be used for understanding the patterns of actual service use or level of experience in a particular PHN.

• The Patient Experience Survey excludes persons aged less than 15 years, persons living in non-private dwellings and the Indigenous Community Strata (encompassing discrete Aboriginal and Torres Strait Islander communities).

• Data for Northern Territory should be interpreted with caution as the Patient Experience Survey excluded the Indigenous Community Strata, which comprises around 25% of the estimated resident population of the Northern Territory living in private dwellings.

• NP - Not available for publication. The estimate is considered to be unreliable. Values assigned to NP in the original data have been set to null.

The global sales of home healthcare software is estimated to be worth USD 4,330.8 million in 2025 and anticipated to reach a value of USD 9,702.0 million by 2035. Sales are projected to rise at a CAGR of 8.4% over the forecast period between 2025 and 2035. The revenue generated by home healthcare software in 2024 was USD 3,995.2 million. The industry is anticipated to exhibit a Y-o-Y growth of 8.2% in 2025.

Attributes	Key Insights
Historical Size, 2024	USD 3,995.2 million
Estimated Size, 2025	USD 4,330.8 million
Projected Size, 2035	USD 9,702.0 million
Value-based CAGR (2025 to 2035)	8.4%

Semi Annual Market Update

Particular	Value CAGR
H1	9.1% (2024 to 2034)
H2	8.8% (2024 to 2034)
H1	8.4% (2025 to 2035)
H2	7.9% (2025 to 2035)

Country-wise Insights

Countries	Value CAGR (2025 to 2035)
United States	7.9%
Germany	7.1%
Japan	6.3%
UK	5.4%
China	8.1%
India	8.7%
Australia	7.4%

Category-wise Insights

Product	Clinical Management Systems (CMS)
Value Share (2025)	34.4%

By Usage	Clinical Homecare Systems
Value Share (2035)	52.0%

Australia Regenerative Medicine Market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of advancing medicines and growing expenses over advancement of the pharmaceutical products. Regenerative Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2027 By Type, By Application, By End User, By Region, Competition Forecast & Opportunities, 2027

Pages	70
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

Australia Employment: Females: Health Care & Social Assistance: Medical & Other Health Care Services data was reported at 507.192 Person th in Feb 2025. This records an increase from the previous number of 498.066 Person th for Nov 2024. Australia Employment: Females: Health Care & Social Assistance: Medical & Other Health Care Services data is updated quarterly, averaging 200.762 Person th from Nov 1984 (Median) to Feb 2025, with 162 observations. The data reached an all-time high of 510.866 Person th in Aug 2023 and a record low of 76.732 Person th in Nov 1984. Australia Employment: Females: Health Care & Social Assistance: Medical & Other Health Care Services data remains active status in CEIC and is reported by Australian Bureau of Statistics. The data is categorized under Global Database’s Australia – Table AU.G023: Employment: by Sex and by Industry.

Health Insurance: No of Policies: Hospital Treatment: by Type: Hospital Treatment Only data was reported at 6,688.000 Unit in Dec 2024. This records an increase from the previous number of 6,599.000 Unit for Sep 2024. Health Insurance: No of Policies: Hospital Treatment: by Type: Hospital Treatment Only data is updated quarterly, averaging 14,768.500 Unit from Sep 1995 (Median) to Dec 2024, with 118 observations. The data reached an all-time high of 1,082,202.000 Unit in Sep 2000 and a record low of 2,372.000 Unit in Dec 2015. Health Insurance: No of Policies: Hospital Treatment: by Type: Hospital Treatment Only data remains active status in CEIC and is reported by Australian Prudential Regulation Authority. The data is categorized under Global Database’s Australia – Table AU.RG006: Health Insurance: Number of Policies.

This dataset presents the footprint of the percentage of adults who felt their GP always or often spent enough time in the preceding 12 months. The data spans the years of 2014-2017 and is aggregated to 2015 Department of Health Primary Health Network (PHN) areas, based on the 2011 Australian Statistical Geography Standard (ASGS).

The data is sourced from the Australian Bureau of Statistics (ABS) 2016-17 Patient Experience Survey, collected between 1 July 2016 and 30 June 2017. It also includes data from previous Patient Experience Surveys conducted in 2013-14, 2014-15 and 2015-16. The Patient Experience Survey is conducted annually by the ABS and collects information from a representative sample of the Australian population. The Patient Experience Survey is one of several components of the Multipurpose Household Survey, as a supplement to the monthly Labour Force Survey. The Patient Experience Survey collects data on persons aged 15 years and over, who are referred to as adults for this data collection.

For further information about this dataset, visit the data source:Australian Institute of Health and Welfare - Patient experiences in Australia Data Tables.

Please note:

• AURIN has spatially enabled the original data using the Department of Health - PHN Areas.

• Percentages are calculated based on counts that have been randomly adjusted by the ABS to avoid the release of confidential data.

• As an indication of the accuracy of estimates, 95% confidence intervals were produced. These were calculated by the ABS using standard error estimates of the proportion.

• Some of the patient experience measures for 2016-17 have age-standardised rates presented. Age-standardised rates are hypothetical rates that would have been observed if the populations studied had the same age distribution as the standard population.

• Crude rates are provided for all years. They should be used for understanding the patterns of actual service use or level of experience in a particular PHN.

• The Patient Experience Survey excludes persons aged less than 15 years, persons living in non-private dwellings and the Indigenous Community Strata (encompassing discrete Aboriginal and Torres Strait Islander communities).

• Data for Northern Territory should be interpreted with caution as the Patient Experience Survey excluded the Indigenous Community Strata, which comprises around 25% of the estimated resident population of the Northern Territory living in private dwellings.

• Rows that contain a "#" in "Interpret with Caution" indicates that the estimate has a relative standard error of 25% to 50%, which indicates a high level of sampling error relative to its value and must be taken into account when comparing this estimate with other values.

• NP - Not available for publication. The estimate is considered to be unreliable. Values assigned to NP in the original data have been set to null.

The Australia Adult Day Care Software Market was valued at USD 386.34 Million in 2024 and is expected to reach USD 545.10 Million by 2030 with a CAGR of 5.88%.

Pages	82
Market Size	2024: USD 386.34 Million
Forecast Market Size	2030: USD 545.10 Million
CAGR	2025-2030: 5.88%
Fastest Growing Segment	Clinical Software
Largest Market	Australia Capital Territory & New South Wales
Key Players	1. Technology One Limited 2. Xplor Technologies Pty Ltd. 3. iCareHealth Pty Ltd. 4. Inerva Pty Ltd. 5. Lumary Pty Ltd. 6. ShiftCare Pty Ltd. 7. Brevity Care Software Pty Ltd. 8. The Access Group Pty Ltd. 9. Tunstall Australasia Pty Ltd. 10. AlayaCare Inc.

Mean trips per week (weekdays only) for baseline and travel targets scenario, by age and sex.

Laboratory Tables: Growing demand for ergonomic and adjustable tables for enhanced comfort and productivity.Laboratory Stools & Benches: Increasing adoption of anti-static and antimicrobial materials for enhanced safety.Laboratory Desk & Storage Cabinets: Rising popularity of modular cabinets with customizable configurations to meet specific storage needs.Pedestal Laboratory Furniture: Growing preference for mobile and flexible units for better space utilization.Laboratory IPS Units: Increasing adoption in life science and healthcare facilities for enhanced safety and isolation.Biological Safety Cabinets: Mandatory use in biological research and healthcare settings for containment of hazardous materials.Fume Hoods: Growing demand for high-performance hoods to protect laboratory personnel from harmful fumes and gases. Recent developments include: March 2023:WALDNER Holding SE & Co. KG (Germany) acquired Laboratory Systems Group Pty Ltd. (Australia) The strategy is to expand its customer base in Australia. As a result of the acquisition, customers in the area will benefit from the company's extensive product line and high-quality laboratory furniture solutions and products, and they will be able to rely on Australian-made service and quality.. Key drivers for this market are: Rising Investment in Research and Development 40, Rise in the number of safety regulations 41; Government Funding for Schools and Colleges 41. Potential restraints include: High initial investment 42. Notable trends are: government funding for schools and colleges fuels market growth.

PM2.5 values baseline and sensitivity scenarios.